Medivation inc
October 14th 2007
   |
|
Medivation inc
Medivation, Inc: Careers
Our talented team works diligently in pursuit of our mission to acquire promising technologies in the late preclinical development phase and develop them quickly and cost ... (more...)
Medivation, Inc: Dimebon
In our first pivotal clinical trial in Alzheimer?s disease, Dimebon demonstrated significant improvement over placebo in all the key aspects of the disease after both six months ... (more...)
MDVN - Medivation, Inc. - Google Finance
Get the latest on Medivation, Inc. (MDVN) including stock quotes, interactive charts, up to date news, high quality discussion groups and more on Google Finance. (more...)
CNBC tag aggregate pages - CNBC.com
A little more than 24 hours after announcing its big, lucrative Alzheimer's drug ... VIDEO | COMPANIES : Medivation, Inc (more...)
Medivation, Inc: Home
Our mission is to efficiently develop innovative therapies for diseases for which there is a significant unmet medical need. Our current clinical development program is focused on ... (more...)
Medivation, Inc. - Press Releases
All Releases; Medivation to Announce Early Positive Data from Phase 1-2 Hormone Refractory Prostate Cancer Trial and Host Conference Call and Webcast on Monday, November 5, 2007 (more...)
MDVN: Summary for MEDIVATION INC - Yahoo! Finance
Get detailed information on MEDIVATION INC (MDVN) including quote performance, Real-Time ECN, technical chart analysis, key stats, insider transactions, and the latest company ... (more...)
EDGAR ONLINE - MEDIVATION, INC. - SEC FILINGS
MEDIVATION, INC.: MDVN (Nasdaq National Mkt) (more...)
Medivation, Inc. - Press Releases
All Releases; Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update Nov 10, 2008 17.8 KB : SAN FRANCISCO, Nov 10, 2008 /PRNewswire ... (more...)
Medivation, Inc. - Press Releases
All Releases : Medivation Common Stock Approved For Listing On The American Stock Exchange Mar 8, 2006 25.3 KB : Medivation Receives FDA Comments On Huntington's ... (more...)